Hip stem movement measured in new study
NCT ID NCT04879732
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study measured how much the ACTIS hip stem moves (subsides) over two years after hip replacement surgery in 64 people with hip osteoarthritis. Researchers used a special X-ray technique called RSA to compare the implant's movement to published data for similar hip stems. The goal was to see if the ACTIS stem stays in place as well as other designs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- ACTIS hip stem (a medical device used in hip replacement surgery)
- What this could lead to
- If successful, this study could confirm that the ACTIS hip stem stays in place well, which may lead to better long-term outcomes for hip replacement patients.
- What could go wrong
- This is a small, completed study focused on measuring implant movement, not on curing disease. Results may not apply to all patients or guarantee better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
Oct 2021
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptomatic osteoarthritis of the hip indicating primary total hip arthroplasty * Aged 21 years or older * Patients willing and able to comply with follow-up requirements and self-evaluations * Ability to give informed consent * Body mass index ≤45 kg/m2 Exclusion Criteria * Active or prior infection * Medical condition precluding major surgery * Medical condition with less than 2 years life expectancy * Overhanging pannus (for anterior approach cohort only) * Prior surgery of the hip involving implantation of hardware (i.e., hemiarthroplasty, internal fixation, pelvic reconstruction near the acetabulum requiring removal) * Skin condition on the area of incision * Multi-level lumbar spine fusion * Ankylosing spondylolithesis * Shortening osteotomy through the femur
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
Nova Scotia Health - Orthopedic
Halifax, Nova Scotia, B3H 2E1, Canada
-
Orthopaedic Innovation Centre
Winnipeg, Manitoba, R2K 2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain waves may reveal how well a sedative blocks surgical pain
- Hip replacement showdown: does the labrum stay or go?
- Can physical therapy beamed into rural homes ease arthritis pain?
- Can catching anemia months before joint surgery speed recovery?
- Can a new turkish questionnaire accurately measure hip osteoarthritis?
- Could a 2-Hour online class before hip surgery boost recovery?